Why The Rally May Not Be Over
Anthrax scares on the east coast plagued a jumpy market Friday, as morning
choppiness deferred to sellers before a substantial afternoon rally pared off
some of the A.M. losses. After three fairly strong weeks, the market was due for
a pause, yet today’s action is saying the upward climb may not be over just yet.
The Nasdaq 100
(
$NDX.X |
Quote |
Chart |
News |
PowerRating) managed to claw its way back into green
territory, ending at 1703.15, up a slight 1.68. Dow Industrials
(
$INDU.X |
Quote |
Chart |
News |
PowerRating)
gained nearly 150 points after the lunch break to end the session down 69.95
at 9340.56 and the S&P 500
(
$SPX.X |
Quote |
Chart |
News |
PowerRating) fell 6.17 to 1091.26.
IPO TheraSense
(
THER |
Quote |
Chart |
News |
PowerRating) saw its shares leap by more than 30% higher
in its first day of trading. THER manufactures and sells self-monitoring glucose
level systems for people with diabetes that substantially reduce the discomfort
of testing. The shares, priced at the open at $19, ended the day 6.00 higher at
25.00.
Juniper Networks
(
JNPR |
Quote |
Chart |
News |
PowerRating) exhibited a revival it has not seen since
the halcyon days of the internet bubble, rising after a gap to the upside to
close at 21.06, up 4.42. Similar glamour names also had good endings to the
week, with Brocade
(
BRCD |
Quote |
Chart |
News |
PowerRating) up 2.62 to 25.36 and Broadcom
(
BRCM |
Quote |
Chart |
News |
PowerRating)
gaining 2.51 to 31.70 at the close of the session.
Chips continued to post gains, with QLogic
(
QLGC |
Quote |
Chart |
News |
PowerRating) adding on 2.82
to the weeks move to close at 37.06. Nvidia
(
NVDA |
Quote |
Chart |
News |
PowerRating) rose 2.43
to recapture the $40 barrier at 40.39, while PMC-Sierra
(
PMCS |
Quote |
Chart |
News |
PowerRating) is
making a run at $20, ending up 2.38 at 18.80. Applied Micro Circuits
(
AMCC |
Quote |
Chart |
News |
PowerRating)
also rose by more than 2 points, up 2.26 at 13.10.
Cepheid
(
CPHD |
Quote |
Chart |
News |
PowerRating) rallied out of its recent pullback, gaining 2.34
to close at 7.81.
Genzyme
(
GENZ |
Quote |
Chart |
News |
PowerRating) was the biotech issue with the strongest
performance, closing near its intraday high up 2.30 to 53.09.
Economic report to be released Monday: Business Inventories for August.